These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30094069)

  • 1. PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer.
    Pereira SP; Jitlal M; Duggan M; Lawrie E; Beare S; O'Donoghue P; Wasan HS; Valle JW; Bridgewater J; Ramage J; Przemioslo R; Hammonds R; Aithal G; Murphy F; Foster G; Sturgess R
    ESMO Open; 2018; 3(5):e000379. PubMed ID: 30094069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and long term efficacy of porfimer sodium photodynamic therapy in locally advanced biliary tract carcinoma.
    Pereira SP; Aithal GP; Ragunath K; Devlin J; Owen F; Meadows H
    Photodiagnosis Photodyn Ther; 2012 Dec; 9(4):287-92. PubMed ID: 23200007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma.
    Park DH; Lee SS; Park SE; Lee JL; Choi JH; Choi HJ; Jang JW; Kim HJ; Eum JB; Seo DW; Lee SK; Kim MH; Lee JB
    Eur J Cancer; 2014 May; 50(7):1259-68. PubMed ID: 24485665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma.
    Cheon YK; Lee TY; Lee SM; Yoon JY; Shim CS
    HPB (Oxford); 2012 Mar; 14(3):185-93. PubMed ID: 22321037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.
    Witzigmann H; Berr F; Ringel U; Caca K; Uhlmann D; Schoppmeyer K; Tannapfel A; Wittekind C; Mossner J; Hauss J; Wiedmann M
    Ann Surg; 2006 Aug; 244(2):230-9. PubMed ID: 16858185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
    Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
    Chiorean EG; Ramasubbaiah R; Yu M; Picus J; Bufill JA; Tong Y; Coleman N; Johnston EL; Currie C; Loehrer PJ
    Oncologist; 2012; 17(1):13. PubMed ID: 22210086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma.
    Harewood GC; Baron TH; Rumalla A; Wang KK; Gores GJ; Stadheim LM; de Groen PC
    J Gastroenterol Hepatol; 2005 Mar; 20(3):415-20. PubMed ID: 15740486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
    Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
    World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy for unresectable cholangiocarcinoma: a comparative effectiveness systematic review and meta-analyses.
    Leggett CL; Gorospe EC; Murad MH; Montori VM; Baron TH; Wang KK
    Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):189-95. PubMed ID: 22959798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term responders to palliative chemotherapy for advanced biliary tract cancer.
    Doherty MK; McNamara MG; Aneja P; McInerney E; Moignard S; Horgan AM; Jiang H; Panzarella T; Jang R; Dhani N; Hedley D; Knox JJ
    J Gastrointest Oncol; 2017 Apr; 8(2):352-360. PubMed ID: 28480074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study.
    Wagner A; Denzer UW; Neureiter D; Kiesslich T; Puespoeck A; Rauws EA; Emmanuel K; Degenhardt N; Frick U; Beuers U; Lohse AW; Berr F; Wolkersdörfer GW
    Hepatology; 2015 Nov; 62(5):1456-65. PubMed ID: 25990106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic biliary treatment of unresectable cholangiocarcinoma: A meta-analysis of survival outcomes and systematic review.
    Rebhun J; Shin CM; Siddiqui UD; Villa E
    World J Gastrointest Endosc; 2023 Mar; 15(3):177-190. PubMed ID: 37034966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp).
    Javle MM; Oh DY; Ikeda M; Yong WP; Hsu K; Lindmark B; McIntyre N; Firth C
    ESMO Open; 2022 Feb; 7(1):100314. PubMed ID: 34922298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma.
    Lee TY; Cheon YK; Shim CS; Cho YD
    World J Gastroenterol; 2012 Oct; 18(39):5589-94. PubMed ID: 23112552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
    Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised controlled trial of temoporfin photodynamic therapy plus chemotherapy in nonresectable biliary carcinoma--PCS Nordic study.
    Hauge T; Hauge PW; Warloe T; Drolsum A; Johansen C; Viktil E; Aabakken L; Buanes T; Konopski Z
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():330-333. PubMed ID: 26415549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-line chemotherapy or in combination with programmed cell death protein-1 antibody in patients with metastatic or recurrent biliary tract cancer.
    Zhao S; Guo XG; Zhang D; Zhou G; Song P; Yang J; Zhang Y; Li P; Hu Y; Wang P
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3541-3547. PubMed ID: 34423859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice.
    Fuks D; Bartoli E; Delcenserie R; Yzet T; Celice P; Sabbagh C; Chatelain D; Joly JP; Cheron N; Dupas JL; Regimbeau JM
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1745-52. PubMed ID: 19780885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
    Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.